Pvg Asset Management Corp Synlogic, Inc. Transaction History

Pvg Asset Management Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 31, 2023	SELL	$0.42 - $0.68 $13,341 - $21,600	-31,765 Reduced 31.7%	68,455 $29,000
Q1 2023 Jul 24, 2023	BUY	$0.56 - $1.07 $16,800 - $32,100	30,000 Added 42.72%	100,220 $63,000
Q4 2022 Feb 14, 2023	BUY	$0.58 - $17.99 $29,782 - $923,786	51,350 Added 272.13%	70,220 $53,000
Q3 2022 Oct 13, 2022	BUY	$0.91 - $14.63 $17,171 - $276,068	18,870 New	18,870 $0

25.5K

Ticker SYBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,229,600
Market Cap $103M
Description
Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase I...

Get notified when there are updates to the investment portfolio of Pvg Asset Management Corp, based on Form 13F filings with the SEC.

Stay updated on Pvg Asset Management Corp with notifications on news.